Filter Results:
(1,244)
Show Results For
- All HBS Web
(1,244)
- People (5)
- News (171)
- Research (928)
- Events (6)
- Multimedia (12)
- Faculty Publications (756)
Show Results For
- All HBS Web
(1,244)
- People (5)
- News (171)
- Research (928)
- Events (6)
- Multimedia (12)
- Faculty Publications (756)
- October 2009 (Revised July 2013)
- Case
Gilead Sciences, Inc.: Access Program
By: V. Kasturi Rangan and Katharine Lee
Gilead Sciences, the U.S. leader in HIV/AIDS medicines, with global sales of $5.4 billion in 2009, had undertaken several innovative actions to make its anti-viral products available to over 100 low- and middle-income countries. Having reached nearly 680,000 patients... View Details
Keywords: Health Care and Treatment; Emerging Markets; Product; Sales; Competitive Strategy; Pharmaceutical Industry; Pharmaceutical Industry
Rangan, V. Kasturi, and Katharine Lee. "Gilead Sciences, Inc.: Access Program." Harvard Business School Case 510-029, October 2009. (Revised July 2013.)
- March 2009
- Teaching Note
Proteus Biomedical: Making Pigs Fly (TN)
Teaching Note for [809051]. View Details
- June 2003 (Revised October 2004)
- Case
Novartis: The Challenge of Success (D)
By: Sandra J. Sucher and Stacy McManus
Supplements the (A) and (B) cases. View Details
Sucher, Sandra J., and Stacy McManus. "Novartis: The Challenge of Success (D)." Harvard Business School Case 603-046, June 2003. (Revised October 2004.)
- June 1999 (Revised June 2000)
- Case
Eckerd Corporation
By: Michael E. Porter and John E. Kelleher
Describes the history and current situation in the retail pharmacy industry, including competition from new merchants and Internet drugstores. Eckerd, one of the top four drug chains, must decide how to position itself for the future. View Details
Keywords: Competition; Alignment; Supply and Industry; Pharmaceutical Industry; Pharmaceutical Industry
Porter, Michael E., and John E. Kelleher. "Eckerd Corporation." Harvard Business School Case 799-141, June 1999. (Revised June 2000.)
- 24 Oct 2016
- News
Health Care Pioneer Giusti Named McCance Senior Fellow at HBS
care, or engineering. Giusti currently serves as faculty cochair of the HBS-Kraft Precision Medicine Accelerator. She has more than two decades of experience in the pharmaceutical industry, having previously held senior positions at G. D.... View Details
Keywords: Susan Young
- 11 May 2020
- Op-Ed
Immigration Policies Threaten American Competitiveness
a vaccine to end the COVID-19 pandemic is Moderna, a Cambridge company with an immigrant co-founder and an immigrant CEO. Another firm already conducting vaccine trials is Inovio Pharmaceuticals of Plymouth Meeting, Pennsylvania, led by... View Details
Keywords: by William R. Kerr
- 01 Sep 2015
- Blog Post
Building a Startup at HBS
prototype which we showcased at HBS and tested out in the NICU to observe its efficacy and nurse uptake. While we each embarked on different paths after the end of first year– from launching a new healthcare venture in Africa, to working at large View Details
- Fast Answer
Transforming Health Care Delivery
Books Books and journal titles on all aspects of the health care, life sciences and pharmaceutical sectors View Details
- 08 Apr 2009
- Research & Ideas
Clayton Christensen on Disrupting Health Care
delivered, the way we use technology, the way pharmaceuticals are developed, the way we educate medical professionals, and who performs what kinds of services. These things are all connected, and changing one piece, or plugging an... View Details
- 23 Jun 2003
- Research & Ideas
Historically Speaking: A Roundtable at HBS
States, Europe, and Japan, it was supposed to examine two sectors: first, the chemical and pharmaceutical industries, which helped bring about the Second Industrial Revolution between the 1880s and 1920s, and second, consumer electronics... View Details
Keywords: by Jim Aisner
- Web
Staff Directory | Baker Library
pharmaceutical companies, health care, travel, and personal finance. Avery holds a master’s degree from Columbia Journalism School, a Fulbright Fellowship to Russia, and a bachelor’s degree in history and international relations from... View Details
- 01 Jun 2000
- News
The Business of Biotech
business and commercial development at Millennium Pharmaceuticals in Cambridge, Massachusetts. "It will revolutionize how medicine is practiced," he states simply. "Right now the doctor listens to your heart with a stethoscope and maybe... View Details
Keywords: Julia Hanna
- 30 Oct 2007
- First Look
First Look: October 30, 2007
Changing Context of Pharmaceutical Risk Mitigation Author:Arthur A. Daemmrich Periodical:Pharmacy in History 49, no. 2 (2007): 61-75 Abstract In the wake of Vioxx, Avandia, and other recent prominent cases of drugs found to cause side... View Details
Keywords: Sean Silverthorne
- 15 Sep 2009
- First Look
First Look: September 15
http://www.nber.org/papers/w11503 Synthesis by Microbes or Chemists? Pharmaceutical Research and Manufacturing in the Antibiotic Era Author:Arthur A. Daemmrich Publication:History and Technology 23, no. 3 (2009): 237-256 Abstract This... View Details
Keywords: Martha Lagace
- Student-Profile
Byungyeon Kim
important Harvard’s worldwide research centers would be to his work. His second year research project involved a study of sales force compensation that resulted from a partnership with a Turkish pharmaceutical company made possible by an... View Details
- 03 Dec 2024
- News
From One to Many
In the years after Keith Ferrazzi (MBA 1992) published Never Eat Alone, he confessed some reluctance in being labeled “the networking guy.” “But 20 years after writing that first book, and after coaching thousands of teams, I’ve finally recognized there’s a... View Details
- 22 Oct 2013
- First Look
First Look: October 22
expenditures on teammates lead to better performance in both sports teams in Canada and pharmaceutical sales teams in Belgium. These results suggest that a minor adjustment to employee bonuses-shifting the focus from the self to... View Details
Keywords: Sean Silverthorne
- Web
Souvenirs & Novelties - The Art of American Advertising
distribute them and local retailers to print their names on them at no cost. James C. Ayer, involved in the pharmaceutical industry, reaped enormous publicity benefits from the distribution of yearly almanacs. Ayer eventually established... View Details
- 14 May 2014
- News
(Re)moving the Needle
that of his father, who was trained as an engineer and ended up in the pharmaceutical industry. He holds MSc and PhD degrees in mechanical engineering from ETH Zurich and MIT, respectively, and he spent a year pursuing advanced studies in... View Details
- 10 Aug 2020
- Research & Ideas
COVID's Surprising Toll on Careers of Women Scientists
COVID-19 is claiming an unexpected career toll among scientific researchers, and particularly on women, new research shows. If you are female, have young children, or work in a lab, you are more likely to feel the career-crunching effects dealt by the pandemic,... View Details